Literature DB >> 15283486

Anosmia after intranasal zinc gluconate use.

Bruce W Jafek1, Miriam R Linschoten, Bruce W Murrow.   

Abstract

BACKGROUND: Zinc is an essential mineral. Beneficial zinc absorption takes place via enteral, parenteral, or cutaneous routes. However, direct application to the olfactory epithelium has been reported to cause loss of smell. Recently, intranasal zinc gluconate has been recommended as a treatment for the common cold. Severe posttreatment hyposmia and anosmia have been observed.
METHODS: The case report of a typical patient is presented and analyzed in detail, followed by a series of patients with severe hyposmia or anosmia after the use of intranasal zinc gluconate.
RESULTS: Although interindividual variation in drug response and drug effect is apparent, the severe hyposmia or anosmia appears to be long lasting or permanent in some cases. The mechanism of olfactory loss is thought to be the direct action of the divalent zinc ion on the olfactory receptor cell.
CONCLUSIONS: Zinc ions are toxic to olfactory epithelium. Reports of severe hyposmia with parosmia or anosmia have occurred after intranasal use of zinc gluconate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15283486

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  19 in total

1.  Effects of zinc gluconate and 2 other divalent cationic compounds on olfactory function in mice.

Authors:  Christopher A Duncan-Lewis; Roy L Lukman; Robert K Banks
Journal:  Comp Med       Date:  2011-08       Impact factor: 0.982

Review 2.  Common cold.

Authors:  Bruce Arroll
Journal:  BMJ Clin Evid       Date:  2011-03-16

Review 3.  The role of metals in mammalian olfaction of low molecular weight organosulfur compounds.

Authors:  Eric Block; Victor S Batista; Hiroaki Matsunami; Hanyi Zhuang; Lucky Ahmed
Journal:  Nat Prod Rep       Date:  2017-05-10       Impact factor: 13.423

Review 4.  Prevention and treatment of the common cold: making sense of the evidence.

Authors:  G Michael Allan; Bruce Arroll
Journal:  CMAJ       Date:  2014-01-27       Impact factor: 8.262

5.  Zinc gluconate toxicity in wild-type vs. MT1/2-deficient mice.

Authors:  Heidi Hsieh; Michael C Horwath; Mary Beth Genter
Journal:  Neurotoxicology       Date:  2016-12-12       Impact factor: 4.294

6.  Acid-sensing ion channel 1 contributes to normal olfactory function.

Authors:  Kiara T Vann; Zhi-Gang Xiong
Journal:  Behav Brain Res       Date:  2017-09-12       Impact factor: 3.332

Review 7.  Nanomedicine in otorhinolaryngology: what does the future hold?

Authors:  Carl M Philpott; Simon Gane; David McKiernan
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-27       Impact factor: 2.503

8.  A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.

Authors:  Michael H Rosenbloom; Terry R Barclay; Maria Pyle; Brian L Owens; Amanda B Cagan; Christopher P Anderson; William H Frey; Leah R Hanson
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

9.  Human sinonasal explant system for testing cytotoxicity of intranasal agents.

Authors:  Jae H Lim; Greg E Davis; Tessa C Rue; Daniel R Storm
Journal:  Int Forum Allergy Rhinol       Date:  2011-12-13       Impact factor: 3.858

10.  Mechanistic studies of the toxicity of zinc gluconate in the olfactory neuronal cell line Odora.

Authors:  Heidi Hsieh; Kavitha Subramanian Vignesh; George S Deepe; Divaker Choubey; Howard G Shertzer; Mary Beth Genter
Journal:  Toxicol In Vitro       Date:  2016-05-12       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.